Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

NRF2 Antikörper (N-Term) (Biotin)

NFE2L2 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal Biotin

Produktnummer ABIN2324960

Datenblatt (PDF)

Target Alle NRF2 (NFE2L2) Antikörper anzeigen

NRF2 (NFE2L2) (Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2))
Bindungsspezifität
21

15

8

8

8

7

7

4

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
N-Term
Reaktivität
112

57

55

5

4

3

2

2

1

1

1

1

1

1
Human
Wirt
105

9

1
Kaninchen
Passende Sekundärantikörper
Klonalität
97

18
Polyklonal
Konjugat
57

9

6

6

4

4

4

4

4

4

4

3

1

1

1

1

1

1
Dieser NRF2 Antikörper ist konjugiert mit Biotin
Applikation
88

51

24

22

17

15

14

14

13

9

7

2

2

2

1

1
Western Blotting (WB), ELISA

Kreuzreaktivität

Human

Kreuzreaktivität (Details)

Calculated cross reactivity: Hu

Produktmerkmale

NFE2L2, NT (NRF2, Nuclear Factor Erythroid 2-related Factor 2, NFE2-related Factor 2, NF-E2-related Factor 2, Nuclear Factor, Erythroid Derived 2, Like 2, HEBP1) (Biotin)

Aufreinigung

Purified by Protein G affinity chromatography.

Immunogen

Synthetic peptide selected from the N-terminal region of human NRF2 (KLH).

Isotyp

IgG

Top Product

Discover our top product NFE2L2 Primärantikörper
anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (pSer40) antibody
NFE2L2 Reaktivität: Human, Ratte, Maus, Schwein WB, ELISA, IHC (p), FACS, IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated

anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (AA 430-480) antibody
NFE2L2 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC (p), FACS, IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated

anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (Internal Region) antibody
NFE2L2 Reaktivität: Human, Ratte WB, IF, IP, IHC (p), ICC, ChIP Wirt: Kaninchen Polyclonal unconjugated

anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (AA 366-605) antibody
NFE2L2 Reaktivität: Human WB, IHC, IF, IP Wirt: Kaninchen Polyclonal unconjugated

anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (AA 382-604) antibody
NFE2L2 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (acLys599) antibody
NFE2L2 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) antibody
NFE2L2 Reaktivität: Human, Ratte, Maus IHC, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (AA 356-589) antibody
NFE2L2 Reaktivität: Human WB, ELISA, IHC Wirt: Maus Monoclonal 1A6G6 unconjugated

anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (N-Term) antibody
NFE2L2 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (pSer40) antibody
NFE2L2 Reaktivität: Human, Ratte, Maus WB, IHC (p), FACS, IF (cc) Wirt: Kaninchen Monoclonal 7G4 unconjugated

Applikationshinweise

Optimal working conditions should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Liquid

Buffer

Supplied as a liquid in PBS, pH 7.2.

Lagerung

-20 °C

Informationen zur Lagerung

-20°C
Target

NRF2 (NFE2L2) (Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2))

Andere Bezeichnung

NFE2L2 (NFE2L2 Produkte)

Synonyme

Nrf2 antikoerper, nfe2l2 antikoerper, wu:fc15g09 antikoerper, wu:fj67e03 antikoerper, NF-E2R2 antikoerper, NRF2 antikoerper, AI194320 antikoerper, nuclear factor, erythroid 2-like 2a antikoerper, nuclear factor, erythroid 2 like 2 S homeolog antikoerper, nuclear factor, erythroid 2 like 2 antikoerper, nuclear factor, erythroid derived 2, like 2 antikoerper, nuclear factor, erythroid 2-like 2 antikoerper, nfe2l2a antikoerper, nfe2l2.S antikoerper, NFE2L2 antikoerper, Nfe2l2 antikoerper

NCBI Accession

NP_006155

UniProt

Q16236

Pathways

ER-Nucleus Signaling, Negative Regulation of intrinsic apoptotic Signaling